ProPhase Labs, Inc. Increase (Decrease) in Other Current Liabilities
ProPhase Labs, Inc. (PRPH) reported Increase (Decrease) in Other Current Liabilities of $611.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2024-03-29
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-12-31 was $641.00K.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-09-30 was -$315.00K, a 118.77% decline year-over-year.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-06-30 was -$3.75M.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-03-31 was $4.04M, a 424.29% increase year-over-year.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for fiscal 2023 was $611.00K.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for fiscal 2022 was -$423.00K.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for fiscal 2021 was -$2.83M, a 255.84% decline from fiscal 2020.
- ProPhase Labs, Inc. increase (decrease) in other current liabilities for fiscal 2020 was $1.81M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 9 month as first filed | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $641.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $326.00K derived: sum of 2 quarters · filed 2024-03-29 | -$3.43M derived: sum of 3 quarters · filed 2024-03-29 | $611.00K 10-K · filed 2024-03-29 | ||
| 2023-09-30 | -$315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.07M derived: sum of 2 quarters · filed 2023-11-13 | -$30.00K 10-Q · filed 2023-11-13 | -$1.15M derived: sum of 4 quarters · filed 2024-03-29 | ||
| 2023-06-30 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $285.00K 10-Q · filed 2023-08-11 | -$838.00K derived: sum of 3 quarters · filed 2024-03-29 | $840.00K derived: sum of 4 quarters · filed 2024-03-29 | ||
| 2023-03-31 | $4.04M 10-Q · filed 2023-05-12 | $2.91M derived: sum of 2 quarters · filed 2024-03-29 | $4.59M derived: sum of 3 quarters · filed 2024-03-29 | $2.84M derived: sum of 4 quarters · filed 2024-03-29 | ||
| 2022-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $555.00K derived: sum of 2 quarters · filed 2024-03-29 | -$1.19M derived: sum of 3 quarters · filed 2024-03-29 | -$423.00K 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$70.00K derived: sum of 2 quarters · filed 2023-11-13 | $700.00K 10-Q · filed 2023-11-13 | -$835.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$978.00K 10-Q · filed 2023-08-11 | -$2.51M derived: sum of 3 quarters · filed 2023-08-11 | -$8.00M derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $770.00K 10-Q · filed 2023-05-12 | -$765.00K derived: sum of 2 quarters · filed 2023-05-12 | -$6.25M derived: sum of 3 quarters · filed 2023-05-12 | -$9.88M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$7.02M derived: sum of 2 quarters · filed 2023-03-29 | -$10.64M derived: sum of 3 quarters · filed 2023-03-29 | -$2.83M 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$9.11M derived: sum of 2 quarters · filed 2022-11-10 | -$1.29M 10-Q · filed 2022-11-10 | -$313.00K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $4.19M 10-Q · filed 2022-08-12 | $5.17M derived: sum of 3 quarters · filed 2022-08-12 | $5.98M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $7.82M 10-Q · filed 2022-05-13 | $8.80M derived: sum of 2 quarters · filed 2022-05-13 | $9.61M derived: sum of 3 quarters · filed 2022-05-13 | $9.70M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.79M derived: sum of 2 quarters · filed 2022-03-31 | $1.88M derived: sum of 3 quarters · filed 2022-03-31 | $1.81M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $904.00K derived: sum of 2 quarters · filed 2021-11-12 | $835.00K 10-Q · filed 2021-11-12 | $860.00K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $26.00K 10-Q · filed 2021-08-13 | $51.00K derived: sum of 3 quarters · filed 2021-08-13 | -$21.00K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$69.00K 10-Q · filed 2021-05-14 | -$44.00K derived: sum of 2 quarters · filed 2021-05-14 | -$116.00K derived: sum of 3 quarters · filed 2021-05-14 | -$61.00K derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$47.00K derived: sum of 2 quarters · filed 2021-03-31 | $8.00K derived: sum of 3 quarters · filed 2021-03-31 | -$247.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | -$17.00K derived: sum of 2 quarters · filed 2020-11-19 | -$272.00K 10-Q · filed 2020-11-19 | $144.00K derived: sum of 4 quarters · filed 2020-11-19 | ||
| 2019-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$200.00K 10-Q · filed 2020-08-11 | $216.00K derived: sum of 3 quarters · filed 2020-08-11 | -$435.00K derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | -$255.00K 10-Q · filed 2020-05-12 | $161.00K derived: sum of 2 quarters · filed 2020-05-12 | -$490.00K derived: sum of 3 quarters · filed 2020-05-12 | -$585.00K derived: sum of 4 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$235.00K derived: sum of 2 quarters · filed 2020-03-26 | -$330.00K derived: sum of 3 quarters · filed 2020-03-26 | -$225.00K 10-K · filed 2020-03-26 | ||
| 2018-09-30 | -$651.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$746.00K derived: sum of 2 quarters · filed 2019-11-12 | -$641.00K 10-Q · filed 2019-11-12 | -$712.00K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $10.00K 10-Q · filed 2019-08-12 | -$61.00K derived: sum of 3 quarters · filed 2019-08-12 | -$28.00K derived: sum of 4 quarters · filed 2019-08-12 | ||
| 2018-03-31 | $105.00K 10-Q · filed 2019-05-14 | $34.00K derived: sum of 2 quarters · filed 2019-05-14 | $67.00K derived: sum of 3 quarters · filed 2019-05-14 | -$3.80M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$38.00K derived: sum of 2 quarters · filed 2019-03-26 | -$3.91M derived: sum of 3 quarters · filed 2019-03-26 | -$1.49M 10-K · filed 2019-03-26 | ||
| 2017-09-30 | $33.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$3.83M derived: sum of 2 quarters · filed 2018-11-14 | -$1.42M 10-Q · filed 2018-11-14 | -$67.00K 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | -$3.87M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$1.45M 10-Q/A · filed 2018-08-20 | -$100.00K 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | $2.42M 10-Q/A · filed 2018-08-20 | |||||
| 2016-09-30 | $618.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | -$375.00K derived: sum of 2 quarters · filed 2018-08-20 | $22.00K 10-Q/A · filed 2018-08-20 | |||
| 2016-06-30 | -$993.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$596.00K 10-Q/A · filed 2018-08-20 | ||||
| 2016-03-31 | $397.00K 10-Q/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |